The road to validating preimplantation genetic testing for aneuploidy; are we there yet?


Like Comment
Related Content

VOLUME 115, ISSUE 3, P585-586, MARCH 01, 2021


K.C. Humm, M.D., David Frankfurter, M.D.


Reflections on "A multicenter, prospective, blinded nonselection study evaluation the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing–based preimplantation genetic testing for aneuploidy assay and impact of biopsy" by Tiegs et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.